Capital Analysts LLC’s Vericel Corp VCEL Stock Holding History

Capital Analysts LLC’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-203	Closed	-$11K	–	1090
2021 Q1	$11K	Buy	+203	New	+$9.19K	﹤0.01%	786

Other funds holding VCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Capital Analysts LLC's VCEL Position: Q2 2021 in Review

Capital Analysts LLC sold out of Vericel Corp (VCEL) in Q2 2021, closing a stake of 203 shares — an estimated $11K sold.

Capital Analysts LLC first reported a position in VCEL in Q1 2021 and held it in 1 quarter. The position peaked at $11K in Q1 2021. 205 funds tracked by Wall St. Rank hold VCEL as of Q2 2021.

Capital Analysts LLC reported no remaining Vericel Corp position as of Q2 2021 after selling out during the quarter.
Capital Analysts LLC sold 203 Vericel Corp shares in Q2 2021, an estimated $11K.
Capital Analysts LLC first reported a position in Vericel Corp in Q1 2021 and held it in 1 quarter.
Capital Analysts LLC's Vericel Corp position peaked at $11K in Q1 2021.
205 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2021.

Based on Capital Analysts LLC's 13F filing for Q2 2021, filed 5 Aug 2021.